Kipp Robins, MD
Otolaryngology · Provo, UTNPI 1396741476
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,042 of the $1,282 with a category attached, or 81.3%. Medical Device Business Services, Inc. accounts for 85.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,104 and has fallen 98.6% since, to $16 in 2025. That places this record below the midpoint for otolaryngology clinicians in UT, where the typical reported total is $1,304.
Across 14 payments — averaging $91.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Pacira Pharmaceuticals Incorporated$45
- Merck$30
- GSK$29
- Acclarent, Inc$24
- Boston Scientific$20
- plus $44 from 3 others
What the payments were for
- Travel & lodging$1,04281%
- Food & beverage$22618%
- Gifts$141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $1,090 |
| Pacira Pharmaceuticals Incorporated | 1 | $45 |
| Merck | 2 | $30 |
| GSK | 2 | $29 |
| Acclarent, Inc | 1 | $24 |
| Boston Scientific | 1 | $20 |
| Optinose US, Inc. | 1 | $18 |
| A-dec, Inc. | 1 | $14 |
| Stryker | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,282 in reported general payments places this provider in the 45th percentile of 104 otolaryngology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 85 | $2,939 |
| Omeprazole | 69 | $1,371 |
| Ciprofloxacin Hcl | 29 | $425 |
| Fluticasone Propionate | 12 | $342 |
| Pantoprazole Sodium | 19 | $217 |
| Cefdinir | 11 | $203 |
| Levothyroxine Sodium | 11 | $175 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $116 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $112 |
| Prednisone | 47 | $88 |
| Azithromycin | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Provo
- Seth RiddleProvo$10K
- Scott ShipleyProvo$8K
- Kirt BeusProvo$2K
- Ryan StephensonProvo$2K
- Christopher HamiltonProvo$1K
- Zachary AndersonProvo$932
- Matthew MoneyProvo$852
- John BitnerLayton$177K
- Steven MillerSalt Lake City$32K
- Michael WilsonSalt Lake City$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.